Old Web
English
Sign In
Acemap
>
authorDetail
>
Ana Cicin-Sain
Ana Cicin-Sain
Novartis
Rivastigmine
Psychiatry
Psychology
Placebo
Adverse effect
7
Papers
2703
Citations
0.03
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A pilot, randomized, open‐label trial assessing safety and pharmakokinetic parameters of co‐administration of rivastigmine with risperidone in dementia patients with behavioral disturbances
2002
International Journal of Geriatric Psychiatry
Mark Weiser
Heschi H. Rotmensch
Amos D. Korczyn
Richard Hartman
Ana Cicin-Sain
Ravi Anand
Show All
Source
Cite
Save
Citations (35)
Presence of vascular risk factors in ad patients predicts greater response to cholinesterase inhibition
2000
Neurobiology of Aging
Vinod Kumar
John Messina
Richard Hartman
Ana Cicin-Sain
Show All
Source
Cite
Save
Citations (0)
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study
2000
The Lancet
Ian G. McKeith
Teodoro del Ser
PierFranco Spano
Murat Emre
Keith Wesnes
Ravi Anand
Ana Cicin-Sain
Roberto Ferrara
René Spiegel
Show All
Source
Cite
Save
Citations (965)
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.
1999
BMJ
Michael Rösler
Ravi Anand
Ana Cicin-Sain
Serge Gauthier
Yves Agid
Peter Dal-Bianco
Hannes B. Stähelin
Richard Hartman
Marguirguis Gharabawi
Show All
Source
Cite
Save
Citations (618)
1